West Pharmaceutical Services, Inc.

NYSE:WST

Medical - Instruments & Supplies

Healthcare
$404.02 +1.56%

+$5.04 today

Market cap
$28.14B
Beta
1.18
P/E (TTM)
43.6
EPS (TTM)
$7.54
Dividend yield
0.26%
52W Low $206.80High $336.82

Volume 0.59M

Average 0.85M

WST Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

West Pharmaceutical Services, Inc.NYSE: WST

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 37.7%

Gross margin was 37.7% in Q2 FY2026, up 2.1 pp from a year earlier. On a trailing-twelve-month basis it was 36.8%, up 1.4 pp year over year. Over 3 fiscal years it narrowed by 3.6 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
37.7%+2.7 pp QoQ
Last fiscal yearDec 2025
35.9%+1.2 pp YoY
LTMJun 2026
36.8%+1.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.1 pp——
1 year+1.2 pp——
3 years-3.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
35.9%
Year-over-year change
+1.2pp

Gross Margin vs competitors

How WST compares with its peers on the latest reported figures

  • WST's LTM Jun 2026 gross margin of 36.8% is the 3rd highest of the 5 companies compared; the peer median is 33.4%.
  • Its year-over-year change of +1.4 pp is the 2nd highest of 5, against a peer median of -2.6 pp.
  • Over three fiscal years its change of -3.6 pp compares with a peer median of -0.2 pp.
WST Competitors Peer median
Gross Margin for WST and competitors
Company Period LTM level YoY 3-year change
BLFSBioLife Solutions, Inc.LTM Mar 202663.9% -19.5 pp+3.0 pp
ICUIICU Medical, Inc.LTM Jun 202637.6% +1.7 pp+6.2 pp
WSTWest Pharmaceutical Services, Inc.LTM Jun 202636.8% +1.4 pp-3.6 pp
STVNStevanato Group S.p.A.LTM Jun 202629.2% +1.1 pp-3.5 pp
ATRAptarGroup, Inc.LTM Jun 202628.3% -6.3 pp-5.4 pp
Peer median (excluding WST) 33.4%-2.6 pp-0.2 pp

Competitors are the stored peer set for WST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.83B2.89B2.95B2.89B3.07B
Cost of Revenue1.66B1.75B1.82B1.89B1.97B
Gross Profit1.17B1.14B1.13B1B1.1B
Gross Margin41.5%39.5%38.4%34.6%35.9%
Research & Development52.8M58.5M68.4M69.1M74.3M
Selling, General & Admin361.9M316.9M353.4M338.5M393.1M
Operating Expenses414.7M375.4M421.8M407.6M485.9M
Depreciation & Amortization122.3M120.6M137.3M155.4M171.4M
EBITDA879.7M808.1M844.1M743.8M770.6M
EBITDA Margin31.1%28.0%28.6%25.7%25.1%
Operating Income758.7M763.5M710.9M594.6M617.4M
Operating Margin26.8%26.5%24.1%20.6%20.1%
Interest Income1M5.1M28M19.6M17.7M
Interest Expense8.5M7.6M8.8M2.9M600K
Other Income / Expenses10.3M(62.9M)4.8M5.6M(2.1M)
Income Before Tax769M700.6M715.7M600.2M615.3M
Pre-Tax Margin27.2%24.3%24.3%20.7%20.0%
Income Tax Expense107.2M114.7M122.3M107.5M121.6M
Net Income661.8M585.9M593.4M492.7M493.7M
Net Margin23.4%20.3%20.1%17.0%16.1%
EPS (Basic)8.907.887.996.756.83
EPS (Diluted)8.677.737.886.696.80
Weighted Avg Shares74.4M74.4M74.3M73M72.3M
Weighted Avg Shares (Diluted)76.3M75.8M75.3M73.7M72.7M

West Pharmaceutical Services, Inc.

NYSE:WST

Intrinsic Alpha fair value

Locked

Current Price

$404.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.